98%
921
2 minutes
20
Mammography is the main method for early detection of breast cancer, which is still a major global health concern. However, inter-reader variability and the inherent difficulty of interpreting subtle radiographic features frequently limit the accuracy of diagnosis. A thorough assessment of deep convolutional neural networks (CNNs) for automated mammogram classification is presented in this work, along with the introduction of two innovative multi-view integration techniques: Dual-Branch Ensemble (DBE) and Merged Dual-View (MDV). By setting aside two datasets for out-of-sample testing, we evaluate the generalizability of the model using six different mammography datasets that represent various populations and imaging systems. We compare a number of cutting-edge architectures on both individual and combined datasets, including ResNet, DenseNet, EfficientNet, MobileNet, Vision Transformers, and VGG19. Both MDV and DBE strategies improve classification performance, according to experimental results. VGG19 and DenseNet both obtained high ROC AUC scores of 0.9051 and 0.7960 under the MDV approach. DenseNet demonstrated strong performance in the DBE setting, achieving a ROC AUC of 0.8033, while ResNet50 recorded a ROC AUC of 0.8042. These enhancements demonstrate how beneficial multi-view fusion is for boosting model robustness. The impact of domain shift is further highlighted by generalization tests, which emphasize the need for diverse datasets in training. These results offer practical advice for improving CNN architectures and integration tactics, which will aid in the creation of trustworthy, broadly applicable AI-assisted breast cancer screening tools.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12387149 | PMC |
http://dx.doi.org/10.3390/jimaging11080247 | DOI Listing |
JCO Glob Oncol
May 2025
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Purpose: Breast cancer remains a significant public health challenge globally, as well as in India, where it is the most frequently diagnosed cancer in females. Significant disparities in incidence, mortality, and access to health care across India's sociodemographically diverse population highlight the need for increased awareness, policy reform, and research.
Design: This review consolidates data from national cancer registries, global cancer databases, and institutional findings from a tertiary care center to examine the epidemiology, clinical challenges, and management gaps specific to India.
J Med Screen
September 2025
The Cancer Registry of Norway, Department of Screening programs, Norwegian Institute of Public Health, Oslo, Norway.
ObjectiveTo study the implications of implementing artificial intelligence (AI) as a decision support tool in the Norwegian breast cancer screening program concerning cost-effectiveness and time savings for radiologists.MethodsIn a decision tree model using recent data from AI vendors and the Cancer Registry of Norway, and assuming equal effectiveness of radiologists plus AI compared to standard practice, we simulated costs, effects and radiologist person-years over the next 20 years under different scenarios: 1) Assuming a €1 additional running cost of AI instead of the €3 assumed in the base case, 2) varying the AI-score thresholds for single vs. double readings, 3) varying the consensus and recall rates, and 4) reductions in the interval cancer rate compared to standard practice.
View Article and Find Full Text PDFJ Natl Cancer Inst
September 2025
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States.
Background: Among childhood cancer survivors, germline rare variants in autosomal dominant cancer susceptibility genes (AD CSGs) could increase subsequent neoplasm (SNs) risks, but risks for rarer SNs and by age at onset are not well understood.
Methods: We pooled the Childhood Cancer Survivor Study and St Jude Lifetime Cohort (median follow-up = 29.7 years, range 7.
PLoS One
September 2025
Institute of Computational Science and Technology, Guangzhou University, Guangzhou, China.
MicroRNAs (miRNAs) are critical regulators of gene expression in cancer biology, yet their spatial dynamics within tumor microenvironments (TMEs) remain underexplored due to technical limitations in current spatial transcriptomics (ST) technologies. To address this gap, we present STmiR, a novel XGBoost-based framework for spatially resolved miRNA activity prediction. STmiR integrates bulk RNA-seq data (TCGA and CCLE) with spatial transcriptomics profiles to model nonlinear miRNA-mRNA interactions, achieving high predictive accuracy (Spearman's ρ > 0.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Objective: This study employs integrated network toxicology and molecular docking to investigate the molecular basis underlying 4-nonylphenol (4-NP)-mediated enhancement of breast cancer susceptibility.
Methods: We integrated data from multiple databases, including ChEMBL, STITCH, Swiss Target Prediction, GeneCards, OMIM and TTD. Core compound-disease-associated target genes were identified through Protein-Protein Interaction (PPI) network analysis.